Invited commentary

J Vasc Surg. 2011 May;53(5):1328. doi: 10.1016/j.jvs.2010.12.006. Epub 2011 May 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage*
  • Drug Administration Schedule
  • Drug Utilization
  • Evidence-Based Medicine
  • Guideline Adherence
  • Hospital Planning*
  • Humans
  • Myocardial Infarction / etiology
  • Myocardial Infarction / prevention & control*
  • Outcome and Process Assessment, Health Care*
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Preoperative Care
  • Quality Improvement*
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Vascular Surgical Procedures / adverse effects*

Substances

  • Adrenergic beta-Antagonists